⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3840273 | 0.78 | — | — | |
| SCHEMBL18131671 | 0.76 | — | — | |
| SCHEMBL4593411 | 0.75 | — | — | |
| SCHEMBL3748544 | 0.74 | — | — | |
| SCHEMBL27909178 | 0.74 | — | — | |
| SCHEMBL2762589 | 0.74 | — | — | |
| SCHEMBL17925957 | 0.74 | — | — | |
| SCHEMBL7629088 | 0.74 | — | — | |
| SCHEMBL3123589 | 0.74 | — | — | |
| SCHEMBL17203510 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110302733-A | Preparation method of double-halogen nitrogen-containing heterocyclic compound | 北京六合宁远科技有限公司 | 2019-10-08 | — | — | CN | claimed |
| EP-3619205-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2022-04-06 | — | — | EP | disclosed |
| CN-110437153-A | hepatitis B core protein allosteric modulators | UNIV INDIANA RES & TECH CORP | 2019-11-12 | — | — | CN | disclosed |
| CN-105934246-B | Tetrahydroquinoline compositions as BET bromodomain inhibitors | 福马疗法公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110302733-A | Preparation method of double-halogen nitrogen-containing heterocyclic compound | 北京六合宁远科技有限公司 | 2019-10-08 | — | — | CN | disclosed |
| CN-110156772-A | Heterocyclic compound, application thereof and pharmaceutical composition containing same | 苏州信诺维医药科技有限公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-109983001-A | 2, 5-disubstituted 3-methylpyrazine and 2,5, 6-trisubstituted 3-methylpyrazine as allosteric SHP2 inhibitors | 锐新医药公司 | 2019-07-05 | — | — | CN | disclosed |
| CN-109890808-A | Therapeutic compounds for prophylactic or therapeutic treatment of HIV viral infections | 吉利德科学公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-106008355-B | Compound and its purposes as BACE inhibitor | 阿斯利康(瑞典)有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-108929333-A | The method for preparing benzo oxygen azepine * compound | 豪夫迈·罗氏有限公司 | 2018-12-04 | — | — | CN | disclosed |
| CN-108834415-A | Substituted tricyclic 1, 4-benzodiazepine ketone derivatives as allosteric modulators of group II metabotropic glutamate receptors | 马瓦隆治疗有限公司 | 2018-11-16 | — | — | CN | disclosed |
| CN-105705500-A | Amide compounds for the treatment of HIV | 吉利德科学公司 | 2016-06-22 | — | — | CN | disclosed |
| CN-105377856-A | Process for preparing benzoxazepine compounds | HOFFMANN LA ROCHE | 2016-03-02 | — | — | CN | disclosed |
| CN-104379560-A | Benzamide derivative | CHUGAI PHARMACEUTICAL CO LTD | 2015-02-25 | — | — | CN | disclosed |
| CN-101784516-B | Dipeptide analogs as coagulation factor inhibitors | BRISTOL MYERS SQUIBB CO | 2014-07-02 | — | — | CN | disclosed |
| CN-103833827-A | Amide compounds, medicine compositions, preparation method and application thereof | SHANGHAI INST PHARM INDUSTRY | 2014-06-04 | — | — | CN | disclosed |
| WO-2013122897-A1 | DIHYDROBENZOXAZINE AND TETRAHYDROQUINOXALINE SODIUM CHANNEL INHIBITORS | AMGEN INC. (US) | 2013-08-22 | — | — | WO | disclosed |
| EP-2222660-A1 | 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF | Schering Corporation (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009064848-A1 | 3-HETEROCYCLIC SUBSTITUTED INDOLE DERIVATIVES AND METHODS OF USE THEREOF | SCHERING CORPORATION (US) | 2009-05-22 | — | — | WO | disclosed |